BackMedline Overview
Medline Inc.

Medline Target Price

See Medline's analyst price targets ($43) vs the current share price.

Get informed when a big investor buys or sells

+ Follow

Share Price

$35.5

Average Target Price

$43.1121.4% upside

9 analysts in the last 4 months

High: $47 | Low: $37

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-08-06Robert W. BairdEric Coldwell$4218.3% upsideOpen
2026-08-06Evercore ISI$399.9% upsideOpen
2026-08-06Stifel Nicolaus$4526.8% upsideOpen
2026-08-06BMO CapitalSean Dodge$4732.4% upsideOpen
2026-08-06RBC Capital$4629.6% upsideOpen
2026-08-06Deutsche Bank$374.2% upsideOpen
2026-06-03Robert W. BairdEric Coldwell$4526.8% upsideOpen
2026-06-01BarclaysGlen Santangelo$4526.8% upsideOpen
2026-05-07Deutsche Bank$4218.3% upsideOpen
2026-03-09Tigress FinancialIvan Feinseth$6069% upsideOpen
2026-02-25Leerink PartnersMichael Cherny$5657.7% upsideOpen
2026-02-25Stifel Nicolaus$5554.9% upsideOpen
2026-02-25Evercore ISI$5554.9% upsideOpen
2026-02-05Tigress Financial$5554.9% upsideOpen
2026-01-21J.P. MorganDavid Larsen$5554.9% upsideOpen
2026-01-12Barclays$5040.8% upsideOpen
2026-01-12BNP Paribas$387% upsideOpen
2026-01-12Wolfe Research$4732.4% upsideOpen
2026-01-12Deutsche Bank$4012.7% upsideOpen
2026-01-12Wells Fargo$4218.3% upsideOpen
2026-01-12BTIG$5040.8% upsideOpen
2026-01-12Mizuho Securities$4835.2% upsideOpen
2026-01-12UBS$4835.2% upsideOpen
2026-01-12Stifel Nicolaus$4629.6% upsideOpen
2026-01-12Redburn PartnersEd Ridley-Day$4218.3% upsideOpen
2026-01-12Leerink Partners$4835.2% upsideOpen
2026-01-12Evercore ISIElizabeth Anderson$5040.8% upsideOpen
2026-01-12Bernstein$4938% upsideOpen
2026-01-12Truist Financial$5246.5% upsideOpen
2026-01-12Piper SandlerJason Bednar$5040.8% upsideOpen
2026-01-12Robert W. BairdEric Coldwell$4835.2% upsideOpen
2026-01-12BMO CapitalSean Dodge$4526.8% upsideOpen
2026-01-12Goldman SachsDavid Roman$4938% upsideOpen
2026-01-12RBC Capital$4732.4% upsideOpen
2026-01-11Morgan StanleyPatrick Wood$4835.2% upsideOpen

Medline (MDLN) FAQ

As of the most recent data, MDLN shows a target price of $43. Scroll down for historical charts and peer comparison views.

If Medline moved to the average analyst target of $43, shares would be roughly 21.4% higher than $35.5. Treat that as a sentiment and modeling checkpoint rather than a precise forecast, and weigh it against your own view of Medline's earnings trajectory.

Besides this target price page, Stockcircle has Medline's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect target price (currently $43) with ownership activity and broader fundamentals.